SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-129680
Filing Date
2024-05-02
Accepted
2024-05-02 21:29:58
Documents
3
Group Members
GILEAD THERAPEUTICS A1 UNLIMITED CO

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d829072dsc13da.htm SC 13D/A 77151
2 EX-99.1 d829072dex991.htm EX-99.1 4245
3 EX-99.2 d829072dex992.htm EX-99.2 128189
  Complete submission text file 0001193125-24-129680.txt   211291
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filed by) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address GEN DE WITTELAAN L11 A3 2800 MECHELEN C9 00000
Business Address GEN DE WITTELAAN L11 A3 2800 MECHELEN C9 00000 3215342900
GALAPAGOS NV (Subject) CIK: 0001421876 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A | Act: 34 | File No.: 005-88880 | Film No.: 24910548
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)